Abstract

Alzheimer’s disease (AD) is the most common type of dementia, affecting 24 million individuals. Clinical and epidemiological studies have found several links between vascular risk factors (VRF), neurovascular unit dysfunction (NVUd), blood-brain barrier breakdown (BBBb) and AD onset and progression in adulthood, suggesting a pathogenetic continuum between AD and vascular dementia. Shared pathways between AD, VRF, and NVUd/BBB have also been found at the molecular level, underlining the strength of this association. The present paper reviewed the literature describing commonly shared molecular pathways between adult-onset AD, VRF, and NVUd/BBBb. Current evidence suggests that VRF and NVUd/BBBb are involved in AD neurovascular and neurodegenerative pathology and share several molecular pathways. This is strongly supportive of the hypothesis that the presence of VRF can at least facilitate AD onset and progression through several mechanisms, including NVUd/BBBb. Moreover, vascular disease and several comorbidities may have a cumulative effect on VRF and worsen the clinical manifestations of AD. Early detection and correction of VRF and vascular disease by improving NVUd/BBBd could be a potential target to reduce the overall incidence and delay cognitive impairment in AD.

Highlights

  • Alzheimer’s disease (AD) is the most common neurodegenerative dementia, affecting two-thirds of individuals with cognitive decline worldwide [1]

  • This review focuses on the main and most common vascular risk factors that can be detected, monitored, and addressed in common clinical practice, their impact on AD

  • Older and emerging data suggest data suggest the urgent need for increased attention on vascular risk factors (VRF) detection, monitoring, and correction in all the ageing populations in order to reduce the burden of cognitive deterioration

Read more

Summary

A Narrative Review

Lorenzo Falsetti 1, *, Giovanna Viticchi 2 , Vincenzo Zaccone 1 , Emanuele Guerrieri 3 , Gianluca Moroncini 4 , Simona Luzzi 2 and Mauro Silvestrini 2. Emergency Medicine Residency Program, Università Politecnica delle Marche, 60121 Ancona, Italy;

Introduction
Research Strategy
Discussion of the Results of the Research Strategy
The Clinical and Epidemiological Link between AD and T2DM
The Role of Insulin Signalling
Shared Molecular Mechanisms between AD and T2DM
The Clinical and Epidemiological Link between AD and Hypertension
Shared Molecular Mechanisms between AD and Hypertension
The Clinical and Epidemiological Link between AD and Dyslipidaemia
Shared Molecular Mechanisms between AD and Dyslipidaemia
The Clinical and Epidemiological Link between AD and Cigarette Smoking
Shared Molecular Mechanisms between AD and Cigarette Smoking
Association between VRF and NVU Dysfunction in AD
Findings
Conclusions
Future Directions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.